Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity

Oncogene

Volumn 23, Issue 4, 2004, Pages 981-990

  Liu, Wai Man ^a,b   Powles, Thomas ^a   Shamash, Jonathan ^a   Propper, David ^a   Oliver, Tim ^a   Joel, Simon ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Apoptosis; Chemosensitivity; Epo; GM CSF; Receptors

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CISPLATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN BCL 2;

ARTICLE; CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL KILLING; CELL LEVEL; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ERYTHROPOIETIN; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 1342322683     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207294     Document Type: Article

References (57)

1. Abels R. (1993). Eur. J. Cancer, S2, 2-8.
2. Acs G, Zhang PJ, Rebbeck TR, Acs P and Verma A. (2002). Cancer, 95, 969-981.
3. Anderson P. (1997). Microbiol. Mol. Biol. Rev., 61, 33-46.
4. Ballif BA and Blenis J. (2001). Cell Growth Differ., 12, 397-408.
5. Berdel WE, Danhauser-Riedl S, Steinhauser G and Winton EF. (1989). Blood, 73, 80-83.
6. Bi S, Hughes T, Bungey J, Chase A, de Fabritiis P and Goldman JM. (1992). Leukemia, 6, 839-842.
7. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J and Rivard N. (2000). J. Cell. Biochem., 79, 355-369.
8. Bradbury D, Zhu YM and Russell N. (1994). Leukaemia, 8, 786-791.
9. Bratthauer GL. (1999). Methods Mol. Biol., 115, 203-214.
10. Chervenick PA and Boggs DR. (1971). Blood, 37, 131-135.
11. Chong ZZ, Kang JQ and Maiese K. (2002). J. Cereb. Blood Flow Metab., 22, 503-514.
12. Clark O, Adams JR, Bennett CL and Djulbegovic B. (2002). BMC Cancer, 2, 23-31.
13. Clarke BJ and Housman D. (1977). Proc. Natl. Acad. Sci. USA, 74, 1105-1109.
14. Da Silva JL, Lacombe C, Bruneval P, Casadevall N, Leporrier M, Camilleri JP, Bariety J, Tambourin P and Varet B. (1990). Blood, 75, 577-582.
15. de Jong MO, Westerman Y, Wagemaker G and Wognum AW. (1997). Stem Cells, 15, 275-285.
16. del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G. (1997). Science, 278, 687-689.
17. Dempke W, Von Poblozki A, Grothey A and Schmoll HJ. (2000). Anticancer Res., 20, 5155-5164.
18. Everson MP, Brown CB and Lilly MB. (1989). Blood, 74, 1472-1476.
19. Fallowfield L, Gagnon D, Zagari M, Cella D, Bresnahan B, Littlewood TJ, McNulty P, Gorzegno G and Freund M. (2002). Br. J. Cancer, 87, 1341-1353.
20. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA and Trzaskos JM. (1998). J. Biol. Chem., 273, 18623-18632.
21. Fukumi S, Horiguchi-Yamada J, Nakada S, Nagai M, Ohno T and Yamada H. (2000). Mol. Cell. Biochem., 206, 43-50.
22. Galea HR and Cogne M. (2002). Clin. Exp. Immunol., 129, 247-253.
23. Garrington TP and Johnson GL. (1999). Curr. Opin. Cell Biol., 11, 211-218.
24. Gerharz CD, Reinecke P, Schneider EM, Schmitz M and Gabbert HE. (2001). Urology, 58, 821-827.
25. Hisakawa H, Sugiyama D, Nishijima I, Xu MJ, Wu H, Nakao K, Watanabe S, Katsuki M, Asano S, Arai K, Nakahata T and Tsuji K. (2001). Blood, 98, 3618-3625.
26. Iversen PO, Hercus TR, Zacharakis B, Woodcock JM, Stomski FC, Kumar S, Nelson BH, Miyajima A and Lopez AF. (1997). J. Biol. Chem., 272, 9877-9883.
27. Iversen PO, Rodwell RL, Pitcher L, Taylor KM and Lopez AF. (1996a). Blood, 88, 2634-2639.
28. Iversen PO, To LB and Lopez AF. (1996b). Proc. Natl. Acad. Sci. USA, 93, 2785-2789.
29. Kapur R and Zhang L. (2001). J. Biol. Chem., 276, 1099-1106.
30. Kolonics A, Apati A, Janossy J, Brozik A, Gati R, Schaefer A and Magocsi M. (2001). Cell Signal., 13, 743-754.
31. Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z and Gutterman JU. (1991). Leukemia, 5, 985-990.
32. Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W and Kurtzberg J. (1993). Ann. Hematol., 67, 267-276.
33. Lee JT and McCubrey JA. (2002). Leukemia, 16, 486-507.
34. Liu WM, Bamford C, Slevin M and Joel SP. (1998). Cancer Chemother. Pharmacol., 41, 343-346.
35. Liu WM, Lawrence AJ and Joel SP. (2002a). Eur. J. Cancer, 38, 842-850.
36. Liu WM, Stimson LA and Joel SP. (2002b). Br. J. Cancer, 86, 1472-1478.
37. Lopez AF, Shannon MF, Hercus T, Nicola NA, Cambareri B, Dottore M, Layton MJ, Eglinton L and Vadas MA. (1992). EMBO J., 11, 909-916.
38. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorph A, Wong G, Clark SC and Vadas MA. (1986). J. Clin. Invest., 78, 1220-1228.
39. Lotem J and Sachs L. (1995). Cell Growth Differ., 6, 647-653.
40. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF and Ahn NG. (1994). Science, 265, 966-970.
41. Matsuda S, Kosako H, Takenaka K, Moriyama K, Sakai H, Akiyama T, Gotoh Y and Nishida E. (1992). EMBO J., 11, 973-982.
42. McCredie KB, Hersh EM and Freireich EJ. (1970). Science, 111, 293-294.
43. McGuckin CP, Uhr MR and Gordon-Smith EC. (1995). Exp. Hematol., 23, 14-20.
44. Orazi A, Cattoretti G, Schiro R, Siena S, Bregni M, Di Nicola M and Gianni AM. (1992). Blood, 79, 2610-2619.
45. Park SA, Park HJ, Lee BI, Ahn YH, Kim SU and Choi KS. (2001). Brain Res. Mol. Brain Res., 93, 18-26.
46. Pless M, Norga K, Carroll M, Heim MH, D'Andrea AD and Mathey-Prevot B. (1997). Blood, 89, 3175-3185.
47. Ramshaw H, Bardy P, Lee M and Lopez A. (2002). Exp. Hematol., 30, 1124-1131.
48. Sachs L. (1996). Proc. Natl. Acad. Sci. USA, 93, 4742-4749.
49. Seger R, Seger D, Lozeman FJ, Ahn NG, Graves LM, Campbell JS, Ericsson L, Harrylock M, Jensen AM and Krebs EG. (1992). J. Biol. Chem., 267, 25628-25631.
50. Shabo Y, Lotem J and Sachs L. (1990). Leukemia, 4, 797-801.
51. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nunez G and Fernandez-Luna JL. (1999). J. Biol. Chem., 274, 22165-22169.
52. Steward WP. (1993). Lancet, 342, 153-157.
53. Vansteenkiste J, Pirker R, Massuti B, Barata F, Font A, Fiegl M, Siena S, Gateley J, Tomita D, Colowick AB and Musil J. (2002). J. Natl. Cancer Inst., 94, 1211-1220.
54. Westenfelder C and Baranowski RL. (2000). Kidney Int., 58, 647-657.
55. Westphal G, Niederberger E, Blum C, Wollman Y, Knoch TA, Rebel W, Debus J and Friedrich E. (2002). Tumori, 88, 15015-15019.
56. Williams GT, Smith CA, Spooncer E, Dexter TM and Taylor DR. (1990). Nature, 343, 76-79.
57. Wu Y, Mehew JW, Heckman CA, Arcinas M and Boxer LM. (2001). Oncogene, 20, 240-251.